Q and A at Downing Street covid 19 press briefing

The transcript discusses the complexity of rolling out a new vaccine compared to the annual flu shot. It highlights the logistical challenges and the collaboration required among various partners, including the NHS, local authorities, and the Armed Services. The importance of regulatory bodies in ensuring the safety and efficacy of vaccines is also emphasized, with a focus on the role of the MHRA in the UK.

What makes the vaccine rollout more complex than the annual flu vaccine?

• The need for more doses

• The involvement of multiple partners and logistical challenges

• The higher cost of vaccines

• The lack of public interest

Which organizations are mentioned as part of the vaccine distribution effort?

• Private pharmaceutical companies

• International health organizations

• Local pharmacies

• The NHS and local authorities

Why does the Prime Minister urge caution regarding the vaccine rollout?

• The public is not interested

• The vaccines are too expensive

• There is a shortage of vaccines

• The vaccines are not yet approved

What is the role of regulators in the vaccine approval process?

• To distribute the vaccines

• To manufacture the vaccines

• To market the vaccines

• To ensure the vaccines are effective and safe

Which regulatory body is mentioned in the context of vaccine approval in the UK?

• WHO

• MHRA

• CDC

• FDA